Stephen W. Webster - 23 Jun 2022 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in fact for Stephen W. Webster
Issuer symbol
NXTC
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
24 Jun 2022, 17:28:13 UTC
Previous filing
23 Jun 2022
Next filing
04 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Stock Option (Right to Buy) Award $0 +14,250 $0.000000 14,250 23 Jun 2022 Common Stock 14,250 $4.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders.